RESEARCH ARTICLE Description of adverse events among adult men following voluntary medical male circumcision: Findings from a circumcision programme in two provinces of South Africa Evans MuchiriID 1*, Salome Charalambous1,2, Sibuse Ginindza1, Mpho Maraisane1, Tintswalo Maringa3, Peter Vranken3, Dayanund Loykissoonlal4, Vincent Muturi-KioiID 5, Candice M. Chetty-Makkan1,2 1 The Aurum Institute, Johannesburg, South Africa, 2 School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, 3 CDC South Africa, Pretoria, South Africa, 4 National Department of Health, Johannesburg, South Africa, 5 International AIDS Vaccine Initiative (IAVI), Nairobi, Kenya * emuchiri@live.co.uk Abstract Background Clinical trials showed strong evidence that voluntary medical male circumcision (VMMC) reduces the acquisition of HIV among heterosexual men by up to 60%. However, VMMC uptake in East and Southern Africa remains suboptimal, with safety concerns identified as a barrier to uptake. We investigated the occurrence and severity of adverse events (AEs) in a routine VMMC programme implemented in Gauteng and North West provinces of South Africa. Methods We describe the frequency and characteristics of AEs using routinely collected data from a VMMC programme implemented between 01 May 2013 and 31 December 2014. The surgi- cal procedure was provided at fixed clinics and mobile units in three districts. Adult men undertaking the procedure were referred for follow-up appointments where AEs were monitored. Results A total of 7,963 adult men were offered the VMMC service with 7,864 (98.8%) met the age and consent requirements for inclusion in a research follow-up after the surgical procedure and were followed-up for potential AEs. In total, 37 (0.5%) patients reported AEs post-sur- gery with infection [11 (29.7%)] and excessive bleeding [11 (29.7%)] commonly reported AEs. In terms of severity, 14 (37.8%) were classified as mild, 13 (35.1%) as moderate, and 10 (27.0%) as severe. Further, 32 (86.5%) of the AEs were classified as definitely related to the surgical procedure, with 36 (97.5%) of all AEs resolving without sequelae. PLOS ONE PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 1 / 12 a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 OPEN ACCESS Citation: Muchiri E, Charalambous S, Ginindza S, Maraisane M, Maringa T, Vranken P, et al. (2021) Description of adverse events among adult men following voluntary medical male circumcision: Findings from a circumcision programme in two provinces of South Africa. PLoS ONE 16(8): e0253960. https://doi.org/10.1371/journal. pone.0253960 Editor: Richard Kao Lee, Weill Cornell Medical College, UNITED STATES Received: August 17, 2020 Accepted: June 16, 2021 Published: August 17, 2021 Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. Data Availability Statement: All data files used for the manuscript are available and will be publicly posted upon acceptance of this submission. Funding: This research study was supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of the Cooperative Agreement Number 5U01GH00522. The funders had no role in study design, data https://orcid.org/0000-0003-4642-2674 https://orcid.org/0000-0003-1620-3999 https://doi.org/10.1371/journal.pone.0253960 http://crossmark.crossref.org/dialog/?doi=10.1371/journal.pone.0253960&domain=pdf&date_stamp=2021-08-17 http://crossmark.crossref.org/dialog/?doi=10.1371/journal.pone.0253960&domain=pdf&date_stamp=2021-08-17 http://crossmark.crossref.org/dialog/?doi=10.1371/journal.pone.0253960&domain=pdf&date_stamp=2021-08-17 http://crossmark.crossref.org/dialog/?doi=10.1371/journal.pone.0253960&domain=pdf&date_stamp=2021-08-17 http://crossmark.crossref.org/dialog/?doi=10.1371/journal.pone.0253960&domain=pdf&date_stamp=2021-08-17 http://crossmark.crossref.org/dialog/?doi=10.1371/journal.pone.0253960&domain=pdf&date_stamp=2021-08-17 https://doi.org/10.1371/journal.pone.0253960 https://doi.org/10.1371/journal.pone.0253960 https://creativecommons.org/publicdomain/zero/1.0/ https://creativecommons.org/publicdomain/zero/1.0/ Conclusion The VMMC programme was able to reach adult men at high risk of HIV acquisition. Reported AEs in the programme were minimal, with the observed safety profile comparable to clinical trial settings, suggesting that VMMC can be safely administered in a programmatic setting. Introduction Models on the impact of voluntary medical male circumcision (VMMC) on the HIV epidemic have reported potential for a significant reduction in HIV incidence in high burden settings of sub-Saharan Africa [1–4]. Globally, the prevalence of male circumcision was estimated at 38.7% in 2015, with majority of circumcisions carried out as part of religious and cultural prac- tices [5]. Results from three clinical trials in Uganda, Kenya, and South Africa showed that VMMC reduced acquisition of heterosexually transmitted HIV in men by up to 60% over 24 months of follow-up [6–9]. VMMC has been recommended for use in combination with other effective strategies for a comprehensive HIV prevention package [9]. The Joint United Nations Pro- gramme on HIV/AIDS (UNAIDS) recommended increasing VMMC uptake as part of a fast track strategy to reduce HIV transmission in high prevalence countries that report low male circumcision prevalence [10,11]. Despite the proven benefits of VMMC, uptake has not been optimal [12,13]. The prevalence of traditional male circumcision varies greatly among countries in East and Southern Africa, from 20% in Uganda to more than 80% in Kenya [14]. In South Africa, the prevalence of all male circumcision is estimated at 44.7%, which is below UNAIDS/WHO target of 90% for 10– 29 year olds by 2021 [15,16]. Even though VMMC is generally accepted among traditionally non-circumcising communities, programmes in sub-Saharan Africa continue to face chal- lenges with demand creation, and high uncertainty around why eligible men prefer not to take up VMMC [13,17]. Reported barriers to VMMC uptake include: limited access to the service; pain caused by the procedure; cultural influences; receiving the VMMC service from a female caregiver; and the cost of the procedure [16,18–20]. Evidence from a systematic review investigating barriers and facilitators of VMMC in countries with low VMMC prevalence and high HIV burden found that the top three barriers were perceptions of the procedure as a foreign cultural prac- tice, fear of pain, and the perception that circumcision was not necessary [15,20,21]. While facilitators included benefits such as reducing health risks and improved hygiene, family and peer support of VMMC, and enhanced sexual performance and satisfaction [20,21]. A serious concern is whether VMMC can be provided safely to large numbers of adult men in developing countries [22–24]. Adverse events (AEs) related to circumcision vary signifi- cantly; reported to be high among men circumcising in traditional (non-clinical) settings at 35.2% and among men circumcising in clinical settings in Kenya at 17.7% with bleeding and wound infection commonly reported [22]. Timing of adverse events among men undertaking VMMC has been described to differ by country and method of circumcision with AEs report- ing hampered by participants not attending all follow-up visits as recommended. Three rando- mised controlled trials of VMMC in Kenya, South Africa, and Uganda reported adverse events of 1.7%, 3.6%, and 7.6% respectively, with the majority classified as mild or moderately severe, and noted to resolve with treatment [6–8]. The frequency of adverse events is a widely used PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 2 / 12 collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared that no competing interests exist. https://doi.org/10.1371/journal.pone.0253960 indicator of VMMC programme quality with studies suggesting that addressing safety issues related to VMMC may improve uptake of the service [25]. The Republic of South Africa set targets related to scaling up the practice of VMMC and incorporated this into the National Strategic Plan, with an aim to reach 80% of men aged 15– 49 years with circumcision services [3,26]. As a result, VMMC clinics opened up mainly target- ing high HIV burden districts in South Africa to ensure that the service was readily available to communities [26]. However, the uptake of VMMC in South Africa has not been optimal even with availability of circumcision procedures that minimize discomfort and recovery time. There is limited published literature in South Africa on adverse events among men undergoing VMMC in a programme setting, outside controlled clinical trials, to inform the safety of scal- ing up the programmes [25]. We investigate the occurrence and severity of adverse events reported in a VMMC pro- gramme implemented in North West and Gauteng provinces of South Africa between 01 May 2013 and 31 December 2014. These findings will inform the safety profile of the procedure among adult men undertaking VMMC in a programmatic setting. Methods We retrospectively analysed data that were collected from a routine VMMC programme implemented by The Aurum Institute between 01 May 2013 and 31 December 2014 among clinics in three districts, Ekurhuleni North (EKN), Ngaka Modiri Molema (NMM) in Gauteng Province, and Dr Ruth Segomotsi Mompati (RSM) in North West Province. The VMMC ser- vices were provided to men 10 years and above at fixed clinics and mobile units using qualified clinicians where the majority of eligible clients were offered the forceps-guided medical cir- cumcision and a small minority offered dorsal slit method as per WHO recommendations [27,28]. Qualified clinicians including medical doctors, clinical associates, and registered nurses completed a one-day theoretical course, followed by a four-day practical training dur- ing which the clinician performed at least twenty procedures under observation from a certi- fied trainer approved by the National Department of Health (NDoH) of South Africa. The training also included client follow-up and adverse event reporting and management. Stan- dard screening procedures were conducted, where any patient with existing medical comor- bidities were first managed before the surgical procedure was performed. Circumcised men were either asked to come back to the VMMC clinic (in EKN) or were referred to an alterna- tive clinic (in NMM and RSM) for follow-up appointments 2 days and 7 days after the surgical procedure. For this study, we only analysed data from adult participants aged 18 years and above, who had provided written informed consent for the research component of the pro- gramme, underwent surgery, and had complete data on AEs. Demographic, social and clinical information, and sexual risk behaviour were collected dur- ing the screening interview and directly entered into a secure laptop on-site at the clinic. A unique VMMC medical reference number was assigned to each participant at each data collec- tion point. All data were stored in a secure server managed by the Aurum Institute. Participants were taken through a pre-circumcision counselling session on the need to abstain from any sexual activity for the 6-week period after the procedure to allow for adequate healing. The counselling session further explored care during the healing process, the effect of VMMC on HIV infection risk, behaviour that could negate the benefits of VMMC, VMMC benefits to sex partners, and the need for condom use while circumcised. We judged partici- pants’ knowledge of the healing process to be comprehensive if they correctly answered all seven questions administered after the pre-surgery counselling. Participants were also asked PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 3 / 12 https://doi.org/10.1371/journal.pone.0253960 about their employment status in the previous three months, and steady employment was used to describe those who had a consistent source of income including permanent employment. Patients were instructed to contact our trained nurses if any unexpected symptoms appeared at any time throughout the recovery period. Patients were expected to return to the appointed clinics for scheduled visits (2 days and 7 days after the procedure) and telephonic follow-up calls were made when a patient missed any scheduled clinic visit. Adult men experiencing AEs after medical circumcision were assessed to determine if these were related to sexual activity during the healing period. The AEs were identified during follow-up tele- phone interviews initiated by the participants to a clinical staff based at the study site or an assessment post-surgery conducted in person at the site during one of the scheduled visits. Cli- nicians and research assistants were further asked to probe to minimize concealing or exagger- ating resumption of sexual activity. The severity of the AEs observed post-surgery used the standard clinical grading of mild, moderate, and severe with a determination of whether the AEs were related to the surgery determined as per WHO guidelines on severity and timing [29]. Mild classification indicated minimal or no intervention was required beyond reassur- ance and observation, while moderate classification included AEs that were neither mild nor severe, required intervention, and were usually managed on-site. Severe classification required extensive intervention with hospital referral or specialist input. The relatedness of AEs to the VMMC procedure used WHO guidelines to categorize these into definite related, likely/possi- bly related, likely unrelated, and definitely unrelated [29]. Infection of the circumcision wound as a result of applying a traditional remedy, or displacement of a device due to sexual activity, were considered definitely related to the procedure, as neither would have occurred had there not been VMMC. Regardless of relatedness, all AEs were recorded and reported, even when the AE seems to be completely unrelated. We analysed data using STATA version 15 (StataCorp, Texas, USA). We summarized socio-demographic characteristics using means and standard deviations for continuous vari- ables and frequencies and associated proportions for categorical variables. The outcome indi- cator of adverse events was summarised using frequencies and proportions, and bivariate associations with baseline characteristics determined as statistically significant if p� 0.05. We did not conduct any inferential analyses, as the number of observed adverse events were few, and with insufficient variation for risk factor analyses. The VMMC study had ethics approval obtained from the Human Research Ethics Commit- tee of University of the Witwatersrand (150602). This project was also reviewed and cleared in accordance with the US Centers for Disease Control and Prevention (CDC) human research protection procedures and was determined to be non-research, program evaluation. Results Sample characteristics and response rates Fig 1 describes the flow of participants during the programme recruitment. Of the 7,963 par- ticipants offered the VMMC service, 7,864 met the inclusion criteria and were included in the study. Follow-up data on adverse events were also available for these participants and were included into the final analytical set. A summary of socio-demographic characteristics appears in Table 1. Of the 7,864 partici- pants, 3,455 (43.9%) were aged between 18 and 24 years, while 7,136 (90.7%) participants had never married. In addition, 4,747 (60.4%) participants had no form of employment, and 7,722 (98.2%) had comprehensive knowledge on benefits and implications of VMMC as assessed during the pre-circumcision counselling. Majority of the participants, 5,581 (71.0%), were Nguni language speakers (iSiZulu/isiXhosa/Sepedi/Tsonga). In conducting the circumcision, PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 4 / 12 https://doi.org/10.1371/journal.pone.0253960 the majority of the surgical procedures used the forceps method of foreskin removal with 7,616 (96.8%), while 161 (2%) of the surgical procedures used the dorsal slit method (See Table 1). Reported adverse events are presented in Table 2. In total, 37 (0.5%) adult men of the 7,846 participants experienced AEs after surgery and were included in the analyses. Of the 37 AEs after the VMMC surgical procedure, 2 (5.0%) were reported the same day of surgery, 13 (35.1%) were reported between –1–2 days post-surgery, 17 (45.9%) reported between 3–7 days post-surgery, and 5 (13.5) reported after 7 days of surgery. The severity grading of the AEs reported indicated that 14 (37.8%) were mild, 13 (35.1%) moderate, and 10 (27.0%) severe. Infection and excessive bleeding were the most common AEs reported at 11 (29.7%) each, while wound disruption during the healing period represented 6 (16.2%) of all AEs. The 10 AEs deemed to be severe were observed as follows: 2 as wound disruption, 3 as excessive bleed- ing, 1 as an infection or sepsis, 1 had insufficient skin removed, 1 was a swelling or hematoma, and 2 were other adverse events. The assessment of the adverse event indicated that 32 (86.5%) of the AEs were definitely related to the circumcision procedure and 36 (97.3%) of the observed AEs were reported to have resolved without sequelae, while the outcome of one was unknown. In relation to the circumcision procedure, 36 (97.3%) of AEs observed were from the forceps procedure, while 1 (2.7%) emanated from the dorsal slit procedure. However, the majority of procedures were performed using the forceps procedures, as noted above. Results from Table 3 report bivariate associations between baseline factors and reported adverse events post-surgery. Results indicate no statistically significant risk factors for develop- ing AEs for all risk factors assessed at the p-value <0.05 significance level. Discussion Even with compelling evidence that VMMC reduces HIV acquisition in men, uptake has been sub-optimal in East and Southern Africa. Safety concerns around the VMMC service have the potential to deter service uptake [13,30–32]. The VMMC programme among adult men in Gauteng and North West Provinces of South Africa was able to reach both mature men aged 25–45 years, and married men. Fig 1. Flow of participants through the voluntary medical male circumcision (VMMC) programme among adult men in Gauteng and North West provinces of South Africa between 01 May 2013 and 31 December 2014. https://doi.org/10.1371/journal.pone.0253960.g001 PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 5 / 12 https://doi.org/10.1371/journal.pone.0253960.g001 https://doi.org/10.1371/journal.pone.0253960 Table 1. Baseline characteristics of adult men presenting for a circumcision programme implemented in Gauteng and North West provinces of South Africa (2013–2014). Characteristics n = 7,864 (%) Age years 18–24 3,455 (43.9) 25–34 3,138 (39.9) 35–44 958 (12.2) 45+ 313 (4.0) Language Sesotho/Setswana 922 (11.7) Nguni (iSiZulu/isiXhosa/Sepedi/Tsonga) 5,581 (71.0) English/Afrikaans 211 (2.7) Other 1,019 (13.0) Missing 131 (1.7) Marital Status Never Married 7,136 (90.7) Married 641 (8.2) Separated/Divorced/Widow 37 (0.5) Missing 50 (0.6) Employment Status None 4,747 (60.4) Some 494 (6.3) Steady 2,569 (32.7) Missing 54 (0.7) HIV status Negative 5,892 (74.9) Positive 239 (3.0) Not done 1,547 (19.7) Missing 186 (2.4) Condom use Never 2,550 (32.4) Inconsistent–some/most times 2,744 (34.9) Consistent–every time 1,989 (25.3) Missing 581 (7.4) Sexual partners None 1,454 (18.5) One 3,904 (49.6) Two or more 2,418 (30.8) Missing 88 (1.1) Circumcision method Forceps 7,616 (96.8) Dorsal Slit 161 (2.1) Sleeve 2 (<0.1) Other 44 (0.6) Missing 41 (0.5) VMMC Knowledge scores from 7 statements Limited (0–6) 10 (0.1) Comprehensive (7) 7,722 (98.2) Missing 132 (1.7) https://doi.org/10.1371/journal.pone.0253960.t001 PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 6 / 12 https://doi.org/10.1371/journal.pone.0253960.t001 https://doi.org/10.1371/journal.pone.0253960 This study sought to assess the frequency and characteristics of adverse events following a VMMC programme. The study found that the incidence of reported adverse events following VMMC was minimal in the programme, with observed rates comparable or lower to those observed in clinical trials evaluating VMMC effectiveness [6–8]. In a multi-site non-rando- mised, prospective cohort study evaluating the safety of PrePex device for male circumcision in six clinics across South Africa, 2.5% of PrePex MMC device participants experienced adverse events [33]. In a prospective study comparing traditional non-clinical and clinical cir- cumcision procedures in Bungoma, Kenya, adverse event rates were observed to be higher [22]. However, these clinical trials had much longer period of follow-up period monitoring for AEs incidence, unlike in this study where follow-up was not as active after 7 days post-surgery. The incidence of adverse events reported in this VMMC programme was low in all age groups and did not differ significantly by marital or employment status. Reported AEs from clinical trials and the VMMC programme data may not be strictly comparable, as clinical trials have more active follow-up procedures that may lack in a routine programme [34]. However, the low incidence of adverse events reported in this study suggests that the quality of the pro- gramme is good and the findings are reassuring for broader implementation efforts. Findings emanating from this study did not identify baseline factors that were significantly related to AEs among adult men. This was as because very few AEs were observed in the pro- gramme. The nature of some of the AEs observed suggested may suggest earlier resumption of sexual activity than recommended in the instructions following assessment and probes by cli- nicians and research staff. Studies have reported that a significant proportion of adult men Table 2. Description of adverse events (AEs) reported post-surgery in adult men in North West and Gauteng provinces of South Africa (May 2013 –December 2014) (n = 7,864). Characteristics n = 37 (%) Timing of AEs reported Day of surgery 2 (5.4) Between 1 and 2 days of surgery 13 (35.1) Between 3 and 7 days of surgery 17 (45.9) After 7 days of surgery 5 (13.5) Severity Mild 14 (37.8) Moderate 13 (35.1) Severe 10 (27.0) Type Appearance/Wound disruption–Post 6 (16.2) Excessive bleeding 11 (29.7) Infection/Sepsis 11 (29.7) Insufficient skin removed 4 (10.8) Other adverse event 2 (5.4) Swelling/Hematoma 3 (8.1) Related to circumcision Definitely related 32 (86.5) Possibly related 1 (2.7) Likely related 1 (2.7) Definitely Unrelated 3 (8.1) Adverse Event Resolution Resolved with no permanent damage 36 (97.3) Unknown 1 (2.7) https://doi.org/10.1371/journal.pone.0253960.t002 PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 7 / 12 https://doi.org/10.1371/journal.pone.0253960.t002 https://doi.org/10.1371/journal.pone.0253960 taking part in VMMC programmes resume sex earlier than the 42-day period recommended by WHO [35]. Resuming sexual activity early, before the surgical wound has completely healed, may negate VMMC benefits in HIV prevention [36] and has been showed to increase the risk of HIV transmission to female partners of HIV-infected men [37]. These analyses had potential limitations. Generally, all AEs may have been underreported as the patient follow-up in our VMMC programme was not as active as it would have been in a clinical trial, with potential for underreporting of AEs in this real-life implementation pro- gramme. A further limitation is the potential underreporting of AEs experienced due to cul- tural reasons [38]. In some African cultures, men are less likely to seek hospitalisation if this may portray them as weak, thus the potential for underreporting of adverse events [39,40]. Attempts to mitigate potential beliefs on AEs reporting were addressed during the pre-surgery counselling to clients by stressing the need for prompt intervention at a health facility if any adverse event was experienced. Based on the knowledge assessment scores, the pre-surgery Table 3. Bivariate associations between adverse events (AEs) and socio-demographic characteristics (n = 7,864) of adult men in Gauteng and North West provinces of South Africa (01-May-2013 and 31-December-2014). No AEs AEs observed Fisher’s exact p-value Characteristics n = 7,827 (%) n = 37 (%) Age categories (years) (0.45) 18–24 3,443 (99.7) 12 (0.3) 25–34 3,119 (99.4) 19 (0.6) 35–44 953 (99.5) 5 (0.5) 45+ 312 (99.7) 1 (0.3) Marital Status (0.35) Never Married 7,104 (99.5) 32 (0.5) Married 636 (99.2) 5 (0.8) Separated/Divorce 20 (100.0) 0 (0.0) Widow 17 (100.0) 0 (0.0) Employment status (0.60) None 4,727 (99.6) 20 (0.4) Some 492 (99.6) 2 (0.4) Steady 2,554 (99.4) 15 (0.6) Language (0.15) Sesotho/Setswana 920 (99.8) 2 (0.2) Nguni (iSiZulu/isiXhosa/Sepedi/Tsonga) 5,557 (99.6) 24 (0.4) English/Afrikaans 209 (99.0) 2 (1.0) Other 1,011 (99.2) 8 (0.8) Circumcision method (0.63) Forceps 7,580 (99.5) 36 (0.5) Dorsal slit 160 (99.4) 1 (0.6) Sleeve 2 (100.0) 0 (0.0) Other 44 (100.0) 0 (0.0) HIV Status (0.10) Negative 5,867 (99.6) 25 (0.4) Positive 236 (98.7) 3 (1.3) Sexual partners (0.18) None 1,451 (99.8) 3 (0.2) One 3,886 (99.5) 18 (0.5) Two or more 2,403 (99.4) 15 (0.6) https://doi.org/10.1371/journal.pone.0253960.t003 PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 8 / 12 https://doi.org/10.1371/journal.pone.0253960.t003 https://doi.org/10.1371/journal.pone.0253960 counselling was well understood by the clients, and we believe participants were empowered to make safer decisions and seek care if indicated. Clinicians involved in performing the circumcision procedures in the VMMC programme were extensively trained by institutions approved by both the Department of Health in South Africa and PEPFAR. This may not be feasible in low resource settings where lower cadres of clinical staff may be required to perform this procedure. Even with extensive training of clini- cal staff involved in this study, there is potential for differences in how AEs were defined and rated due to inter-rater variability, hence potential source for bias. Evidence from a study assessing the quality of VMMC service offered by mid-level health workers in South Africa showed no difference in the number of adverse events reported when comparing clinical asso- ciates and medical doctors [41]. Further, this study reported on AEs from a VMMC pro- gramme where majority of procedures were performed using the Forceps guide method, it is not clear how this would differ in setting where other methods are preferred. We were not able to conduct more elaborate risk factor analysis using models to identify factors associated with AEs following VMMC because of low number of observed AEs. Additional data are needed from longer time frames or multiple sites to further understand risk factors. The project was implemented as part of a routine service as such data collected were not as detailed as would be required for a clinical trial. Some indicators including employment status were not as spe- cific and we could not tell variation of AEs by type of employment as potential differences by type of labour would be expected. Conclusion This study found very low incidence of AEs reported among adult men above 18 years follow- ing the circumcision procedures performed in a VMMC programme in South Africa. The low incidence of observed AEs in this programmatic setting suggest that scaling up VMMC pro- grammes can be done in a safely manner without an apparent increase in reported AEs. Supporting information S1 File. (XLS) Acknowledgments The authors would like to thank all of the participants for taking part in the study. Addition- ally, we would like to thank staff from The Aurum Institute, and the Imbizo research team. We also wish to acknowledge the University of California, San Francisco’s International Trainee- ships in AIDS Prevention Studies (ITAPS) for facilitating the drafting of the manuscript. Disclaimer The findings and conclusions in this report are those of the author and do not necessarily rep- resent the official position of the funding agencies. Author Contributions Conceptualization: Salome Charalambous, Mpho Maraisane, Dayanund Loykissoonlal, Vin- cent Muturi-Kioi, Candice M. Chetty-Makkan. Data curation: Sibuse Ginindza, Candice M. Chetty-Makkan. Formal analysis: Evans Muchiri, Sibuse Ginindza, Vincent Muturi-Kioi. PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 9 / 12 http://www.plosone.org/article/fetchSingleRepresentation.action?uri=info:doi/10.1371/journal.pone.0253960.s001 https://doi.org/10.1371/journal.pone.0253960 Funding acquisition: Salome Charalambous, Mpho Maraisane, Tintswalo Maringa, Peter Vranken, Dayanund Loykissoonlal. Investigation: Evans Muchiri, Salome Charalambous, Mpho Maraisane, Candice M. Chetty- Makkan. Methodology: Evans Muchiri, Salome Charalambous, Sibuse Ginindza, Vincent Muturi-Kioi, Candice M. Chetty-Makkan. Project administration: Sibuse Ginindza, Mpho Maraisane, Tintswalo Maringa, Peter Vran- ken, Dayanund Loykissoonlal, Candice M. Chetty-Makkan. Resources: Sibuse Ginindza, Tintswalo Maringa, Peter Vranken, Dayanund Loykissoonlal. Software: Evans Muchiri, Sibuse Ginindza. Supervision: Mpho Maraisane. Validation: Evans Muchiri. Visualization: Evans Muchiri. Writing – original draft: Evans Muchiri, Vincent Muturi-Kioi, Candice M. Chetty-Makkan. Writing – review & editing: Evans Muchiri, Salome Charalambous, Sibuse Ginindza, Mpho Maraisane, Tintswalo Maringa, Peter Vranken, Dayanund Loykissoonlal, Vincent Muturi- Kioi, Candice M. Chetty-Makkan. References 1. Stuart RM, Fraser-Hurt N, Kerr CC, Mabusela E, Madi V, Mkhwanazi F, et al. The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there. Journal of the International AIDS Society. 2018; 21(1). 2. Haacker M, Fraser-Hurt N, Gorgens M. Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis. PLoS Med. 2016; 13(5):e1002012. 3. Hankins C, Warren M, Njeuhmeli E. Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geogra- phy. PloS one. 2016; 11(10):e0160699. https://doi.org/10.1371/journal.pone.0160699 PMID: 27783613 4. Njeuhmeli E, Opuni M, Schnure M, Tchuenche M, Stegman P, Gold E, et al. Scaling Up Voluntary Medi- cal Male Circumcision for Human Immunodeficiency Virus Prevention for Adolescents and Young Adult Men: A Modeling Analysis of Implementation and Impact in Selected Countries. Clin Infect Dis. 2018; 66(suppl_3):S166–S72. https://doi.org/10.1093/cid/cix969 PMID: 29617778 5. Morris BJ, Wamai RG, Henebeng EB, Tobian AA, Klausner JD, Banerjee J, et al. Estimation of country- specific and global prevalence of male circumcision. Population health metrics. 2016; 14:4. https://doi. org/10.1186/s12963-016-0073-5 PMID: 26933388 6. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled inter- vention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005; 2(11):e298. https://doi.org/10.1371/journal.pmed.0020298 PMID: 16231970 7. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV preven- tion in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007; 369(9562):643–56. https://doi.org/10.1016/S0140-6736(07)60312-2 PMID: 17321310 8. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007; 369(9562):657–66. https://doi. org/10.1016/S0140-6736(07)60313-4 PMID: 17321311 9. Hinkle LE, Toledo C, Grund JM, Byams VR, Bock N, Ridzon R, et al. Bleeding and Blood Disorders in Clients of Voluntary Medical Male Circumcision for HIV Prevention—Eastern and Southern Africa, 2015–2016. MMWR Morbidity and mortality weekly report. 2018; 67(11):337–9. https://doi.org/10. 15585/mmwr.mm6711a6 PMID: 29565839 PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 10 / 12 https://doi.org/10.1371/journal.pone.0160699 http://www.ncbi.nlm.nih.gov/pubmed/27783613 https://doi.org/10.1093/cid/cix969 http://www.ncbi.nlm.nih.gov/pubmed/29617778 https://doi.org/10.1186/s12963-016-0073-5 https://doi.org/10.1186/s12963-016-0073-5 http://www.ncbi.nlm.nih.gov/pubmed/26933388 https://doi.org/10.1371/journal.pmed.0020298 http://www.ncbi.nlm.nih.gov/pubmed/16231970 https://doi.org/10.1016/S0140-6736%2807%2960312-2 http://www.ncbi.nlm.nih.gov/pubmed/17321310 https://doi.org/10.1016/S0140-6736%2807%2960313-4 https://doi.org/10.1016/S0140-6736%2807%2960313-4 http://www.ncbi.nlm.nih.gov/pubmed/17321311 https://doi.org/10.15585/mmwr.mm6711a6 https://doi.org/10.15585/mmwr.mm6711a6 http://www.ncbi.nlm.nih.gov/pubmed/29565839 https://doi.org/10.1371/journal.pone.0253960 10. WHO. Male Circumcision: Rationale for including Male Circumcision in the Proposal. UNAIDS & World Health Organization, 31 Aug. 2011. 2011. 11. Kripke K, Reed J, Hankins C, Smiley G, Laube C, Njeuhmeli E. Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Tar- gets. PloS one. 2016; 11(10):e0155734. https://doi.org/10.1371/journal.pone.0155734 PMID: 27783681 12. Njeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, Heard N, et al. Voluntary medical male circumci- sion: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 2011; 8(11):e1001132. https://doi.org/10.1371/journal.pmed.1001132 PMID: 22140367 13. Westercamp N, Bailey RC. Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saha- ran Africa: a review. AIDS Behav. 2007; 11(3):341–55. https://doi.org/10.1007/s10461-006-9169-4 PMID: 17053855 14. Wilcken A, Keil T, Dick B. Traditional male circumcision in eastern and southern Africa: a systematic review of prevalence and complications. Bulletin of the World Health Organization. 2010; 88(12):907– 14. https://doi.org/10.2471/BLT.09.072975 PMID: 21124715 15. Morris BJ, Wamai RG, Henebeng EB, Tobian AA, Klausner JD, Banerjee J, et al. Erratum to: Estimation of country-specific and global prevalence of male circumcision. Population health metrics. 2016; 14:11. https://doi.org/10.1186/s12963-016-0080-6 PMID: 27051352 16. UNAIDS TJUPoA. A framework for voluntary medical male circumcision: effective HIV prevention and a gateway to improved adolescent boys’ & men’s health in Eastern and Southern Africa by 2021. 2016. 17. Wirth KE, Semo BW, Ntsuape C, Ramabu NM, Otlhomile B, Plank RM, et al. Triggering the decision to undergo medical male circumcision: a qualitative study of adult men in Botswana. AIDS care. 2016; 28 (8):1007–12. https://doi.org/10.1080/09540121.2015.1133797 PMID: 26754167 18. Hatzold K, Mavhu W, Jasi P, Chatora K, Cowan FM, Taruberekera N, et al. Barriers and motivators to voluntary medical male circumcision uptake among different age groups of men in Zimbabwe: results from a mixed methods study. PloS one. 2014; 9(5):e85051. https://doi.org/10.1371/journal.pone. 0085051 PMID: 24802746 19. Gilbert HN, Wyatt MA, Asiimwe S, Turyamureeba B, Tumwesigye E, Van Rooyen H, et al. Messaging Circumstances and Economic Pressures as Influences on Linkage to Medical Male Circumcision follow- ing Community-Based HIV Testing for Men in Rural Southwest Uganda: A Qualitative Study. AIDS Res Treat. 2018; 2018:8387436. https://doi.org/10.1155/2018/8387436 PMID: 29854445 20. Carrasco MA, Wilkinson J, Kasdan B, Fleming P. Systematic review of barriers and facilitators to volun- tary medical male circumcision in priority countries and programmatic implications for service uptake. Global public health. 2018:1–21. https://doi.org/10.1080/17441692.2018.1465108 PMID: 29695201 21. Ledikwe JH, Mawandia S, Kleinman NJ, Ntsuape C, Ramabu NM, Semo BW, et al. Voluntary Medical Male Circumcision and Perceived Sexual Functioning, Satisfaction, and Risk Behavior: A Qualitative Study in Botswana. Arch Sex Behav. 2020. 22. Bailey RC, Egesah O, Rosenberg S. Male circumcision for HIV prevention: a prospective study of com- plications in clinical and traditional settings in Bungoma, Kenya. Bull World Health Organ. 2008; 86 (9):669–77. https://doi.org/10.2471/blt.08.051482 PMID: 18797642 23. Kohler PK, Namate D, Barnhart S, Chimbwandira F, Tippet-Barr BA, Perdue T, et al. Classification and rates of adverse events in a Malawi male circumcision program: impact of quality improvement training. BMC health services research. 2016; 16:61. https://doi.org/10.1186/s12913-016-1305-x PMID: 26888178 24. Kohler PK, Tippett Barr BA, Kang’ombe A, Hofstee C, Kilembe F, Galagan S, et al. Safety, Feasibility, and Acceptability of the PrePex Device for Adult Male Circumcision in Malawi. Journal of acquired immune deficiency syndromes (1999). 2016; 72 Suppl 1:S49–55. 25. Bochner AF, Feldacker C, Makunike B, Holec M, Murenje V, Stepaniak A, et al. Adverse event profile of a mature voluntary medical male circumcision programme performing PrePex and surgical procedures in Zimbabwe. Journal of the International AIDS Society. 2017; 19(1):21394. https://doi.org/10.7448/ IAS.20.1.21394 PMID: 28362066 26. Kripke K, Chen PA, Vazzano A, Thambinayagam A, Pillay Y, Loykissoonlal D, et al. Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces. PloS one. 2016; 11(7):e0157071. https://doi.org/10.1371/journal.pone.0157071 PMID: 27409079 27. WHO. Circumcision methods for adolescent boys and men. Geneva: World Health Organisaion: (https://www.who.int/hiv/pub/malecircumcision/chapter_9.pdf accessed on 25 March 2020). 2013. PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 11 / 12 https://doi.org/10.1371/journal.pone.0155734 http://www.ncbi.nlm.nih.gov/pubmed/27783681 https://doi.org/10.1371/journal.pmed.1001132 http://www.ncbi.nlm.nih.gov/pubmed/22140367 https://doi.org/10.1007/s10461-006-9169-4 http://www.ncbi.nlm.nih.gov/pubmed/17053855 https://doi.org/10.2471/BLT.09.072975 http://www.ncbi.nlm.nih.gov/pubmed/21124715 https://doi.org/10.1186/s12963-016-0080-6 http://www.ncbi.nlm.nih.gov/pubmed/27051352 https://doi.org/10.1080/09540121.2015.1133797 http://www.ncbi.nlm.nih.gov/pubmed/26754167 https://doi.org/10.1371/journal.pone.0085051 https://doi.org/10.1371/journal.pone.0085051 http://www.ncbi.nlm.nih.gov/pubmed/24802746 https://doi.org/10.1155/2018/8387436 http://www.ncbi.nlm.nih.gov/pubmed/29854445 https://doi.org/10.1080/17441692.2018.1465108 http://www.ncbi.nlm.nih.gov/pubmed/29695201 https://doi.org/10.2471/blt.08.051482 http://www.ncbi.nlm.nih.gov/pubmed/18797642 https://doi.org/10.1186/s12913-016-1305-x http://www.ncbi.nlm.nih.gov/pubmed/26888178 https://doi.org/10.7448/IAS.20.1.21394 https://doi.org/10.7448/IAS.20.1.21394 http://www.ncbi.nlm.nih.gov/pubmed/28362066 https://doi.org/10.1371/journal.pone.0157071 http://www.ncbi.nlm.nih.gov/pubmed/27409079 https://www.who.int/hiv/pub/malecircumcision/chapter_9.pdf https://doi.org/10.1371/journal.pone.0253960 28. WHO. Guideline on the use of devices for adult male circumcision for HIV prevention. Geneva: World Health Organization; (http://apps.who.int/iris/bitstream/10665/93178/1/9789241506267_eng.pdf, accessed 23 March 2020). 2013. 29. WHO. Adverse Event Action Guide For Voluntary Medical Male Circumcision (VMMC) by Surgery or Device 2nd Edition, 2016 2016. 30. Chilimampunga C, Lijenje S, Sherman J, Nindi K, Mavhu W. Acceptability and feasibility of early infant male circumcision for HIV prevention in Malawi. PloS one. 2017; 12(4):e0175873. https://doi.org/10. 1371/journal.pone.0175873 PMID: 28414783 31. Lukobo MD, Bailey RC. Acceptability of male circumcision for prevention of HIV infection in Zambia. AIDS Care. 2007; 19(4):471–7. https://doi.org/10.1080/09540120601163250 PMID: 17453585 32. Albert LM, Akol A, L’Engle K, Tolley EE, Ramirez CB, Opio A, et al. Acceptability of male circumcision for prevention of HIV infection among men and women in Uganda. AIDS Care. 2011; 23(12):1578–85. https://doi.org/10.1080/09540121.2011.579939 PMID: 21732902 33. Lebina L, Milovanovic M, Otwombe K, Abraham P, Manentsa M, Nzenze S, et al. PrePex circumcision surveillance: Adverse events and analgesia for device removal. PloS one. 2018; 13(3):e0194271. https://doi.org/10.1371/journal.pone.0194271 PMID: 29579082 34. Hellar A, Plotkin M, Lija G, Mwanamsangu A, Mkungume S, Christensen A, et al. Adverse events in a large-scale VMMC programme in Tanzania: findings from a case series analysis. Journal of the Interna- tional AIDS Society. 2019; 22(7):e25369. https://doi.org/10.1002/jia2.25369 PMID: 31368235 35. Odoyo-June E, Rogers JH, Jaoko W, Bailey RC. Factors associated with resumption of sex before com- plete wound healing in circumcised HIV-positive and HIV-negative men in Kisumu, Kenya. Journal of acquired immune deficiency syndromes (1999). 2013; 62(4):465–70. 36. Kalichman SC, Eaton L, Pinkerton SD. Male circumcision in HIV prevention. Lancet. 2007; 369 (9573):1597; author reply 8–9. 37. Grund JM, Bryant TS, Toledo C, Jackson I, Curran K, Zhou S, et al. Correction to: Association of Male Circumcision with Women’s Knowledge of its Biomedical Effects and With Their Sexual Satisfaction and Function: A Systematic Review. AIDS Behav. 2020; 24(1):344. https://doi.org/10.1007/s10461- 019-02553-1 PMID: 31214865 38. Kelly A, Kupul M, Fitzgerald L, Aeno H, Neo J, Naketrumb R, et al. "Now we are in a different time; vari- ous bad diseases have come." Understanding men’s acceptability of male circumcision for HIV preven- tion in a moderate prevalence setting. BMC Public Health. 2012; 12:67. https://doi.org/10.1186/1471- 2458-12-67 PMID: 22264256 39. Khumalo-Sakutukwa G, Lane T, van-Rooyen H, Chingono A, Humphries H, Timbe A, et al. Understand- ing and addressing socio-cultural barriers to medical male circumcision in traditionally non-circumcising rural communities in sub-Saharan Africa. Cult Health Sex. 2013; 15(9):1085–100. https://doi.org/10. 1080/13691058.2013.807519 PMID: 23815101 40. Woods VD, Montgomery SB, Belliard JC, Ramirez-Johnson J, Wilson CM. Culture, black men, and prostate cancer: what is reality? Cancer Control. 2004; 11(6):388–96. https://doi.org/10.1177/ 107327480401100606 PMID: 15625526 41. Ngcobo S, Wolvaardt JE, Bac M, Webb E. The quality of voluntary medical male circumcision done by mid-level workers in Tshwane District, South Africa: A retrospective analysis. PloS one. 2018; 13(1): e0190795. https://doi.org/10.1371/journal.pone.0190795 PMID: 29351311 PLOS ONE Description of AEs among adult men following VMMC in South Africa PLOS ONE | https://doi.org/10.1371/journal.pone.0253960 August 17, 2021 12 / 12 http://apps.who.int/iris/bitstream/10665/93178/1/9789241506267_eng.pdf https://doi.org/10.1371/journal.pone.0175873 https://doi.org/10.1371/journal.pone.0175873 http://www.ncbi.nlm.nih.gov/pubmed/28414783 https://doi.org/10.1080/09540120601163250 http://www.ncbi.nlm.nih.gov/pubmed/17453585 https://doi.org/10.1080/09540121.2011.579939 http://www.ncbi.nlm.nih.gov/pubmed/21732902 https://doi.org/10.1371/journal.pone.0194271 http://www.ncbi.nlm.nih.gov/pubmed/29579082 https://doi.org/10.1002/jia2.25369 http://www.ncbi.nlm.nih.gov/pubmed/31368235 https://doi.org/10.1007/s10461-019-02553-1 https://doi.org/10.1007/s10461-019-02553-1 http://www.ncbi.nlm.nih.gov/pubmed/31214865 https://doi.org/10.1186/1471-2458-12-67 https://doi.org/10.1186/1471-2458-12-67 http://www.ncbi.nlm.nih.gov/pubmed/22264256 https://doi.org/10.1080/13691058.2013.807519 https://doi.org/10.1080/13691058.2013.807519 http://www.ncbi.nlm.nih.gov/pubmed/23815101 https://doi.org/10.1177/107327480401100606 https://doi.org/10.1177/107327480401100606 http://www.ncbi.nlm.nih.gov/pubmed/15625526 https://doi.org/10.1371/journal.pone.0190795 http://www.ncbi.nlm.nih.gov/pubmed/29351311 https://doi.org/10.1371/journal.pone.0253960